Takenaka, Masaru
Kuroda, Koji
Tanaka, Fumihiro
Article History
Received: 12 November 2023
Accepted: 14 December 2023
First Online: 28 January 2024
Declarations
:
: Fumihiro Tanaka has received lecture fees from MSD, Bristol-Meyers Squibb, Boehringer Ingelhaim, Ono, Johonson & Johonson, Medtronic, Taiho, Eli Lilly, Astra Zeneca, Daiichi-Sankyo and Chugai, and has received research grants from MSD, Bristol-Meyers Squibb, Ono, Boehringer Ingelhaim, Eli Lilly, Astra Zeneca, Chugai, Amgen and Abbvie. Masaru Takenaka and Koji Kuroda reports no conflicts of interest.
: This review article involves no studies of human or animal subjects performed by the author. In all studies, informed consent was obtained from all patients for inclusion in the respective studies.